A nanounit strategy reverses immune suppression of exosomal PD-L1 and is associated with enhanced ferroptosis

PD-L1 is frequently expressed on the surface of cancer cells and can be excreted from cancer cells in exosomes. Here, the authors generate a nanotherapy that combines an inhibitor of exosome production and an inducer of ferroptosis, enhancing the response to immune checkpoint blockade therapy.

Bibliographic Details
Main Authors: Guohao Wang, Lisi Xie, Bei Li, Wei Sang, Jie Yan, Jie Li, Hao Tian, Wenxi Li, Zhan Zhang, Ye Tian, Yunlu Dai
Format: Article
Language:English
Published: Nature Publishing Group 2021-09-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-021-25990-w
id doaj-d0e25276be7f4139860cffdfc046439d
record_format Article
spelling doaj-d0e25276be7f4139860cffdfc046439d2021-10-03T11:50:13ZengNature Publishing GroupNature Communications2041-17232021-09-0112111210.1038/s41467-021-25990-wA nanounit strategy reverses immune suppression of exosomal PD-L1 and is associated with enhanced ferroptosisGuohao Wang0Lisi Xie1Bei Li2Wei Sang3Jie Yan4Jie Li5Hao Tian6Wenxi Li7Zhan Zhang8Ye Tian9Yunlu Dai10Cancer Centre, Faculty of Health Sciences, University of MacauCancer Centre, Faculty of Health Sciences, University of MacauCancer Centre, Faculty of Health Sciences, University of MacauCancer Centre, Faculty of Health Sciences, University of MacauCancer Centre, Faculty of Health Sciences, University of MacauCancer Centre, Faculty of Health Sciences, University of MacauCancer Centre, Faculty of Health Sciences, University of MacauCancer Centre, Faculty of Health Sciences, University of MacauCancer Centre, Faculty of Health Sciences, University of MacauCancer Centre, Faculty of Health Sciences, University of MacauCancer Centre, Faculty of Health Sciences, University of MacauPD-L1 is frequently expressed on the surface of cancer cells and can be excreted from cancer cells in exosomes. Here, the authors generate a nanotherapy that combines an inhibitor of exosome production and an inducer of ferroptosis, enhancing the response to immune checkpoint blockade therapy.https://doi.org/10.1038/s41467-021-25990-w
collection DOAJ
language English
format Article
sources DOAJ
author Guohao Wang
Lisi Xie
Bei Li
Wei Sang
Jie Yan
Jie Li
Hao Tian
Wenxi Li
Zhan Zhang
Ye Tian
Yunlu Dai
spellingShingle Guohao Wang
Lisi Xie
Bei Li
Wei Sang
Jie Yan
Jie Li
Hao Tian
Wenxi Li
Zhan Zhang
Ye Tian
Yunlu Dai
A nanounit strategy reverses immune suppression of exosomal PD-L1 and is associated with enhanced ferroptosis
Nature Communications
author_facet Guohao Wang
Lisi Xie
Bei Li
Wei Sang
Jie Yan
Jie Li
Hao Tian
Wenxi Li
Zhan Zhang
Ye Tian
Yunlu Dai
author_sort Guohao Wang
title A nanounit strategy reverses immune suppression of exosomal PD-L1 and is associated with enhanced ferroptosis
title_short A nanounit strategy reverses immune suppression of exosomal PD-L1 and is associated with enhanced ferroptosis
title_full A nanounit strategy reverses immune suppression of exosomal PD-L1 and is associated with enhanced ferroptosis
title_fullStr A nanounit strategy reverses immune suppression of exosomal PD-L1 and is associated with enhanced ferroptosis
title_full_unstemmed A nanounit strategy reverses immune suppression of exosomal PD-L1 and is associated with enhanced ferroptosis
title_sort nanounit strategy reverses immune suppression of exosomal pd-l1 and is associated with enhanced ferroptosis
publisher Nature Publishing Group
series Nature Communications
issn 2041-1723
publishDate 2021-09-01
description PD-L1 is frequently expressed on the surface of cancer cells and can be excreted from cancer cells in exosomes. Here, the authors generate a nanotherapy that combines an inhibitor of exosome production and an inducer of ferroptosis, enhancing the response to immune checkpoint blockade therapy.
url https://doi.org/10.1038/s41467-021-25990-w
work_keys_str_mv AT guohaowang ananounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis
AT lisixie ananounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis
AT beili ananounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis
AT weisang ananounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis
AT jieyan ananounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis
AT jieli ananounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis
AT haotian ananounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis
AT wenxili ananounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis
AT zhanzhang ananounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis
AT yetian ananounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis
AT yunludai ananounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis
AT guohaowang nanounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis
AT lisixie nanounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis
AT beili nanounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis
AT weisang nanounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis
AT jieyan nanounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis
AT jieli nanounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis
AT haotian nanounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis
AT wenxili nanounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis
AT zhanzhang nanounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis
AT yetian nanounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis
AT yunludai nanounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis
_version_ 1716845227023532032